No intervention

Drug identity has not yet been verified against registry records

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

TrialSponsorPhaseStatusPrimary completion
A Safety and Efficacy Study of GTX-102 in Subjects With Deletion- or Nondeletion-type Angelman Syndrome (AS)NCT07157254RAREPhase 2Terminated2026-10-30Actual

Regulatory dates and decisions

No regulatory events match this view.This does not mean no FDA events have occurred.